Wuhan Asia Heart Hospital
PrivateLast Round
Series D
Feb 10, 2022
Total Funding Raised
$550M
Company Overview
Wuhan Asia Heart Hospital is a healthcare company that operates a network of heart hospitals specializing in heart surgery and cardiology examinations, supported by a skilled medical team to facilitate rapid recovery from heart-related conditions.
Sector
Healthcare & Life Sciences
Verticals
Medical Imaging, Telemedicine, EHR & EMR, Patient Engagement
Business Model
B2C
Customer Profile
Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Wuhan Asia Heart Hospital Comparables
Compare Wuhan Asia Heart Hospital with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Hong Kong Asia Medical Group | 78% | |
| Chinese Academy of Medical Sciences | 78% | |
| Huazhong University of Science and Technology | 76% |
For institutional investors. Book with your work email.
Wuhan Asia Heart Hospital Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series D | Feb 10, 2022 | ||||
| Series C | Sep 19, 2018 | ||||
| Series B | Jan 13, 2017 |
For institutional investors. Book with your work email.
Wuhan Asia Heart Hospital Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Industrial and Commercial Bank of China | Series D |
| Primavera Capital Group | Series D |
| ICBC International Holdings Limited | Series D |
| Legend Capital | Series D |
| Country Garden Ventures Capital | Series D |
| BOCOM International Holdings Company Limited | Series D |
| Hudson Bay Capital Management | Series D |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- May 4, 2025
Monthly visitors increased 138% MoM, reaching 7.6K.
- Feb 25, 2025
Monthly visitors grew 108% MoM, reaching 10.4K.
For institutional investors. Book with your work email.
Wuhan Asia Heart Hospital Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Wuhan Asia Heart Hospital's valuation, stock price, and market status.
Is Wuhan Asia Heart Hospital a public or private company?
Wuhan Asia Heart Hospital is a private company.
What is the current stock price of Wuhan Asia Heart Hospital?
Wuhan Asia Heart Hospital is a private company, so its shares have no public market price. Caplight tracks Wuhan Asia Heart Hospital's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Wuhan Asia Heart Hospital worth (valuation)?
Valuation information for Wuhan Asia Heart Hospital is not publicly available.
Can I buy Wuhan Asia Heart Hospital stock?
Wuhan Asia Heart Hospital shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Wuhan Asia Heart Hospital's last funding round?
Wuhan Asia Heart Hospital's most recent funding round was Series D on February 10, 2022.
Who are the main investors in Wuhan Asia Heart Hospital?
Key investors in Wuhan Asia Heart Hospital include Primavera Capital Group, Country Garden Ventures Capital, HongShan Capital Group (HSG), Primavera Capital Group, General Atlantic.
Will Wuhan Asia Heart Hospital IPO soon?
No public IPO plans have been announced for Wuhan Asia Heart Hospital.
How can I track Wuhan Asia Heart Hospital secondary market activity?
Caplight tracks bids, offers, and trades in Wuhan Asia Heart Hospital's shares on secondary markets.